Ivosidenib

TypeName: Business Offer
Category:
Offer Date:2019/05/22
Country: United States
Summary: Ivosidenib is an oral inhibitor that specifically inhibits a mutated form of IDH1 in the cytoplasm, which blocks the proliferation of tumor cells expressing IDH1. https://www.bocsci.com/ivosidenib-cas-1448347-49-6-item-474585.html
Description:
OfferId: 4231
Name:Alex Brown
Telphone:
Categories